Key Insights

Highlights

Success Rate

76% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

9.1%

9 terminated out of 99 trials

Success Rate

76.3%

-10.2% vs benchmark

Late-Stage Pipeline

11%

11 trials in Phase 3/4

Results Transparency

14%

4 of 29 completed with results

Key Signals

4 with results76% success

Data Visualizations

Phase Distribution

62Total
Not Applicable (31)
P 1 (4)
P 2 (16)
P 3 (9)
P 4 (2)

Trial Status

Completed29
Recruiting26
Not Yet Recruiting20
Unknown10
Terminated9
Active Not Recruiting3

Trial Success Rate

76.3%

Benchmark: 86.5%

Based on 29 completed trials

Clinical Trials (99)

Showing 20 of 20 trials
NCT06701656Phase 2RecruitingPrimary

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab

NCT06703073Phase 2RecruitingPrimary

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)

NCT06701682Phase 2RecruitingPrimary

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab

NCT06701669Phase 2RecruitingPrimary

JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart

NCT07669558Not ApplicableRecruitingPrimary

Electrical Impedance Tomography-Guided Identification of the Optimal Lateral Position in Postoperative ARDS

NCT07726940RecruitingPrimary

Immune Mechanisms and ECMO Strategies for Moderate-to-Severe ARDS

NCT07629973Not ApplicableNot Yet RecruitingPrimary

A Study of the Determinants of Neurological Outcomes in Patients With Acute Respiratory Distress Syndrome

NCT07025096Not ApplicableCompleted

Evaluating Artificial Intelligence-Based Clinical Decision Support for Sepsis and ARDS

NCT07713420Not ApplicableNot Yet RecruitingPrimary

COMPARISON OF LUNG RECRUITABILITY ASSESSMENT BY HYSTERESIS RATIO AND RECRUITMENT-TO-INFLATION RATIO, AND PEEP TITRATION IN ARDS.

NCT07711964Phase 4RecruitingPrimary

Identifying an Optimal Corticosteroid Dosage Regimen for Acute Respiratory Distress Syndrome

NCT07317050Phase 3RecruitingPrimary

Clinical Trial With Aprotinin in the Acute Respiratory Distress Syndrome Treatment

NCT06844617Not ApplicableActive Not RecruitingPrimary

A Trial of Staff Time With Proned Patients in the ICU Using the 'BathMat'

NCT06697717Not ApplicableCompleted

End-expiratory Transpulmonary Pressure-guided vs Electrical Impedance Tomography-guided PEEP Titration Methods in Patients With Intra-abdominal Hypertension Combined With Acute Respiratory Distress Syndrome: a Randomized Crossover Controlled Study

NCT07576660Phase 3Not Yet RecruitingPrimary

Dexamethasone Treatment for Sepsis-associated Acute Respiratory Distress Syndrome: a Multicenter, Randomised, Double-blinded, Controlled Trial

NCT07673250Not ApplicableNot Yet RecruitingPrimary

Personalized Ventilator Settings for Patients on ECMO

NCT07666503Not Yet RecruitingPrimary

Assessment of the Reproducibility of the Recruitment-to-inflation Ratio (R/I Ratio) Measurement in Patients With Acute Respiratory Distress Syndrome

NCT07528196Phase 3Not Yet RecruitingPrimary

Study of Xuanbai Shengmai Decoction in the Treatment of Acute Respiratory Distress Syndrome

NCT05847517Phase 3TerminatedPrimary

Metoprolol in Acute Respiratory Distress Syndrome (MAIDEN)

NCT02574169Not ApplicableTerminated

Alveolar Recruitment Maneuvers, Intracerebral Hemodynamic and Oxygenation

NCT07090460RecruitingPrimary

Pulmonary Overdistension Assessment With Electrical Impedance Tomography in Patients With Acute Respiratory Distress Syndrom in Prone Position.

Scroll to load more

Research Network

Activity Timeline